Australian Clinical Labs Limited
ASX ACL.AX
Australian Clinical Labs Limited Cash and Short-Term Investments for the year ending June 30, 2024: USD 17.90 M
-
Australian Clinical Labs Limited Cash and Short-Term Investments for the year ending June 30, 2023 was USD 13.28 M, a -27.03% change year over year.
-
Australian Clinical Labs Limited Cash and Short-Term Investments for the year ending June 30, 2022 was USD 18.20 M, a -31.11% change year over year.
-
Australian Clinical Labs Limited Cash and Short-Term Investments for the year ending June 30, 2021 was USD 26.42 M, a 8.46% change year over year.
-
Australian Clinical Labs Limited Cash and Short-Term Investments for the year ending June 30, 2020 was USD 24.36 M, a 575.89% change year over year.
| Date | Cash and Short-Term Investments | Receivables | Inventory | Goodwill |
|---|
Don’t Miss A Beat
| CEO | Ms. Melinda McGrath |
| IPO Date | May 14, 2021 |
| Location | Australia |
| Headquarters | 1868-1892 Dandenong Road |
| Employees | 4,900 |
| Sector | Healthcare |
| Industries | |
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Past 5 years
USD 0.87
StockViz Staff
February 6, 2025
Any question? Send us an email